Siemens Drags DAX Down, But Munich Re and Bayer Cushion the Fall

Market Overview

The euphoria that recently lifted Germanys DAX to record heights faded on Thursday, largely due to the performance of Siemens. The technology giant's quarterly results and future business outlook weighed heavily on the index, compounded by the announcement of plans to spin off its medical technology subsidiary. The DAX faced broad-based sell-offs, further pressured in the afternoon as U.S. markets opened with losses. The recent upward momentum stalled despite the resolution of the U.S. government shutdown, which did little to inspire investor confidence. Siemens' disappointing earnings report led to significant declines not only for its own shares but also for Siemens Energy and Siemens Healthineers, as well as RWE. By the end of the Xetra trading session, the DAX had dropped 1.4% to 24,041.62 points, just above its daily low.

Economic Concerns and Market Reactions

Andreas Lipkow, a market expert, expressed caution, noting that the end of the U.S. shutdown might be followed by negative economic data, as missed reports are released. This uncertainty poses a challenge for the Federal Reserves upcoming interest rate decisions, according to Jürgen Molnar from Robomarkets. In contrast, the MDAX displayed resilience, buoyed by positive reactions to several mid-sized companies' earnings reports. It briefly surpassed the 30,000-point mark, closing with a slight gain of 0.12% at 29,610.57 points. The longest U.S. government shutdown ended with President Donald Trump's signature on a temporary budget. However, this budget only extends until the end of January, raising concerns about another potential shutdown in February.

Company Performances

Siemens ended the day as the DAXs biggest loser, dropping 9.4%. Siemens Healthineers also saw a decline of 3.4%. Investors were digesting both the quarterly results and the planned spin-off of the medical technology division. Other companies also released their financials on Thursday. Deutsche Telekom and Merck KGaA captured significant attention. Merck's shares rose by 5% after surprising the market with strong quarterly numbers, reaching their highest point since May. Deutsche Telekom, initially up, reversed to a 0.2% loss, with its performance in the domestic market falling short of expectations, though offset by stronger results elsewhere, according to JPMorgan. The Allianz stock gained 0.3%, benefiting from positive quarterly results from Generali, which reported a profit increase due to fewer natural disaster claims. Munich Res shares rose by 1.2%, supported by a favorable analyst comment. Bayer also performed well, climbing 2.8% as multiple analysts expressed optimism following their earnings report.

Broader Market Movements

Infineon enjoyed a boost from its previous days earnings report, particularly due to potential growth from AI data centers. However, by the close of trading, its shares had fallen 1.7% due to profit-taking. In the MDAX, Renk saw a 7% increase thanks to robust quarterly results and a significant order backlog. Conversely, Aixtron faced an 8% decline, landing at the bottom of the index. In the SDAX, Heidelberger Druck continued its recovery with a 9.8% rise, following LBBWs buy recommendation after the companys half-year report. Eckert & Ziegler climbed 8.4% on strong third-quarter earnings, showing resilience after earlier challenges. Jost Werke also rose 8.2%, driven by solid profitability. Overall, while Siemens weighed heavily on the DAX, positive earnings reports from other companies provided some relief, highlighting the mixed sentiments in the market.